AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review.

Hsu, Chih-Hung; Huang, Yi-Hsiang; Lin, Shi-Ming; Hsu, Chiun

Hsu, Chih-Hung; Huang, Yi-Hsiang; Lin, Shi-Ming; Hsu, Chiun.

Affiliation

Hsu CH; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.
Huang YH; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Lin SM; Institute of Clinical Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
Hsu C; Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan.

Liver Cancer ; 11(2): 94-112, 2022 Apr.

Article in En | MEDLINE | ID: mdl-35634427

Key words

AXL receptor tyrosine kinase; Cabozantinib; Hepatocellular carcinoma; Mesenchymal-to-epithelial transition receptor tyrosine kinase; Tumor microenvironment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Language: En Journal: Liver Cancer Year: 2022 Document type: Article

Fulltext

XML

PubMed Links

Search on Google